VALIDATION OF SUBJECTIVE BENEFIT AFTER INTRAPROSTATIC BOTULINUS TOXIN A INJECTION IN PATIENTS WITH PROSTATIC HYPERTROPHY – AN EVIDENCE BY REAL-TIME TISSUE ELASTOGRAPHY

1964 VALIDATION OF SUBJECTIVE BENEFIT AFTER INTRAPROSTATIC BOTULINUS TOXIN A INJECTION IN PATIENTS WITH PROSTATIC HYPERTROPHY – AN EVIDENCE BY REAL-TIME TISSUE ELASTOGRAPHY Takeo Hiraoka*, Hiroaki Shiina, Shogo Inoue, Masahiro Sumura, Shinji Urakami, Satoshi Honda, Koji Wake, Mikio Igawa. Izumo, Japan. INTRODUCTION AND OBJECTIVE: Recent reports have indicated intraprostatic botulinus toxin A (BTX-A) injection as an attractive alternative to TUR-P. The purpose of this study is to validate the clinical usefulness of BTX-A injection into the prostate as a minimal invasive treatment for BPH. METHODS: Twenty-two BPH patients (average age 74 years old) were employed in this study. The eligible criteria for inclusion are